Medimix International Appoints New Managing Director EMEA

Jan. 26, 2010 - PRLog -- London (Jan 25, 2010) - Medimix International announced today the appointment of Joao Saraiva as Managing Director for Europe, Middle East and Africa (EMEA). For this newly created function, Joao will be based in the Medimix offices in London and will be responsible for overseeing the activities of the company in Europe, as well as emerging markets of Middle East and Africa.

Joao Saraiva brings over 25 years of comprehensive experience in global pharmaceutical research with a specialization in oncology (Takeda, Merck Serono, Chugai), as well as knowledge at the agency level. He was formerly Deputy Chief Operating Office of InterCAM, which was subsequently merged with the Cegedim group. He brings extensive expertise in international healthcare marketing research, as well as sales force optimization and product portfolio development.

Industry experts have advised that the challenge for the life sciences industry in 2010 and the years to come will be the need to move away from high-cost Western niche markets and to serve global mass markets at lower costs. Under Joao Saraiva, Medimix EMEA will move to meet this challenge and assert itself as a key player in improving global healthcare outcomes, assisting companies in this shift in thinking to make sure their products deliver real value in a more complex world.

“We are delighted to see Joao Saraiva joining our London office,” comments Henry Gazay, CEO of Medimix International. “Joao is a recognized expert in our field, and he will play an instrumental role in developing our activities towards existing and new clients in Europe, Middle East and Africa. Aside from the traditional Top 5 European markets where Medimix has operated for more than 20 years, we see an increasing interest in Eastern Europe, select Middle Eastern and African Markets, that represent new potential of growth for our clients. The addition of new staff and a stronger management team in London is our direct response to this need.”


“The opportunity to work with Medimix International is an exciting challenge in my professional career,” remarked Joao. “Together with the technology, Medimix combines the knowhow that is necessary for the successful delivery of new market research products and services adapted to the business environment and demands of our clients. Moreover, being an international researcher, with Medimix I found the right team for the global research and operational capabilities that are requested by the pharmaceutical industry.”

About Medimix International

Medimix International is a dynamic provider of advanced marketing research solutions for the healthcare industry worldwide. Medimix’s proprietary panel provides direct access to more than 500,000 physicians and healthcare professionals from around the world, making it one of the largest panels in the industry.

The staff of Medimix International is composed of professionals with marketing research, pharmaceutical and medical backgrounds. Medimix specializes in global research.

# # #

Medimix International - provides advanced marketing research solutions for the healthcare industry worldwide, with a proprietary panel of over 500,000 healthcare professionals in 60 countries -one of the largest panels in the industry.
www.medimix.net.